Create a free research account to view current pricing and place an order.
Mechanism of action
MOTS-C is a mitochondrial-derived peptide researched for metabolic flexibility, AMPK-linked signaling, insulin-sensitivity pathways, substrate utilization, and cellular stress adaptation.
Half-life & pharmacokinetics
Half-life: Short systemic exposure.
Short systemic exposure; functional mitochondrial signaling may outlast plasma presence. Research protocols often use two to three exposures weekly.
Research dosing reference
5-15 mg two to three times weekly, often in short blocks rather than indefinite continuous use.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 2.5 mg | 50 units |
| 5 mg | 100 units |
| 10 mg | 200 units |
| 15 mg | 300 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
| 40 mg | 3 mL BAC Water preferred for higher-content vial | 0.133 mg/unit |
Injection timing
Often used earlier in the day or around training/energy-demand windows; avoid late timing if sleep disruption occurs.
Beginner escalation
Increase gradually because mitochondrial agents can produce fatigue, malaise, or adaptation-type responses.
Side-effect mitigation
Monitor fatigue, malaise, flushing, nausea, headache, or exercise-tolerance changes. Avoid stacking multiple mitochondrial agents at high exposure initially.
Stack compatibility
Often paired conceptually with SS-31, MOTS-C, NAD+, glutathione, or metabolic protocols, using conservative sequencing for interpretability.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Mitochondrial protocols often run 4-12 weeks, followed by reassessment of fatigue, exercise tolerance, recovery, sleep, and energy consistency before continuing or repeating.
Frequently asked questions
What is MOTS-C and how does it work?
MOTS-C is a mitochondrial-derived peptide researched for metabolic flexibility, AMPK-linked signaling, insulin-sensitivity pathways, substrate utilization, and cellular stress adaptation.
What is the half-life of MOTS-C?
MOTS-C: Short systemic exposure. Short systemic exposure; functional mitochondrial signaling may outlast plasma presence. Research protocols often use two to three exposures weekly.
How is MOTS-C reconstituted for research?
Preferred reconstitution for the 10 mg vial is 2 mL BAC Water, giving 0.050 mg/unit. Always confirm concentration math before any use. Research use only.
Is MOTS-C FDA approved?
No. MOTS-C is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration